MucoClear - Hypertonic sodium chloride

Indications

Nebulised hypertonic sodium chloride solution (3–7%) is used to mobilise lower respiratory tract secretions in mucous consolidation (e.g. cystic fibrosis).

Nebulised hypertonic sodium chloride solution (3%) is used for mild to moderate acute viral bronchiolitis in infants.

Recipients may benefit from the use of an inhaled bronchodilator before treatment with hypertonic sodium chloride to reduce the risk of temporary irritation, such as coughing, hoarseness, or reversible bronchoconstriction, which may occur.

Sizes Available

MucoClear 3% nebuliser solution, sodium chloride 3%, 20 × 4 ml
MucoClear 3% nebuliser solution, sodium chloride 3%, 60 × 4 ml
MucoClear 6% nebuliser solution, sodium chloride 6%, 20 × 4 ml
MucoClear 6% nebuliser solution, sodium chloride 6%, 60 × 4 ml

More on: Mucolytics , Hypertonic sodium chloride